Speaker


JL Ross | CEO & Co-founder, Alleo Labs 

Dr. J. Ross co-founded Alleo Labs and serves as CEO and president. Dr. Ross brings nearly a decade of industry experience in drug discovery and AI, including his previous executive role as Vice President and Head of Neuroscience at Immuneering Corporation (NASDAQ: IMRX), where he co-led the company to its IPO in 2021. He received his bachelor’s degree from the University of Michigan and holds a doctoral degree in Neuroscience from Brown University. Dr. Ross also trained as a neuroscientist and computational biologist at the National Institutes of Health for over 10 years. Currently, he is a board member of the Alzheimer’s Association, a mentor at Nucleate, William H. Gates Sr. Fellow, and 2025 Henri Termeer Fellow.


Alleo Labs 

Alleo Labs is a San Francisco-based biotechnology startup focused on developing precision medicines for neurodegenerative diseases, including Parkinson’s and Alzheimer’s. The company integrates advanced AI, large-scale biological datasets, and translational neuroscience to identify disease-driving inflammatory mechanisms in the brain. Alleo focuses on emerging therapeutic modalities to reduce neuroinflammation with high specificity. By combining computational discovery with rigorous experimental validation, Alleo aims to generate first-in-class and best-in-class programs that address drivers of neurodegeneration and advance them efficiently toward clinical development.

Powered by:
Hyphen Projects   

Let's connect:           
Book a ticket
FAQ
Contact Us
Privacy Policy
Terms & Conditions 
Chamber of Commerce: 32110979
VAT no: NL8184.34.491.B01
          
 
 

                                    

Keep me informed Download the sponsor brochure


© Copyright 2025 by Hyphen Projects